Top Markets
Coin of the day
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
Rang in Aktien #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Aktienkurs
$26.13
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$873.45M
Veränderung (1 Tag)
-2.99%
Veränderung (1 Jahr)
-
Land
US
Handel SpyGlass Pharma, Inc. Common Stock (SGP)

Kategorie

Kursverlauf für SpyGlass Pharma, Inc. Common Stock (SGP)
Höchster Schlusskurs: $25.93 am 2026-08-01

Niedrigster Schlusskurs: $28.20 am 2026-02-01
Kursverlauf der Aktie von SpyGlass Pharma, Inc. Common Stock von 2026 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
Nicht genügend Daten für die angegebenen Daten.
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH